Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Tow Keang Lim (Singapore, Singapore), T.K. Lim, J.S.K. Ng, M.Y. Chew. Clinical utility of the Xpert MTB/RIF test in induced sputum. Eur Respir J 2015; 46: Suppl. 59, 1527

Member's Comments

No comment yet.

Related content which might interest you: Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012 Sensitivity of Xpert MTB/RIF in induced sputum in smear negative pulmonary tuberculosis patients? Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era. Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 Effect of history of tuberculosis on specificity of Xpert MTB/RIF Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020 Year: 2020 Study of diagnostic sensitivity for mycobacterium tuberculosis(MTB) by smear, culture and Xpert MTB/RIF assay in pleural specimens obtained by medical thoracoscopy. Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018 Year: 2019 Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Source: Eur Respir J 2016; 47: 575-587 Year: 2016 Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021 Year: 2021 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014